Slidesets
  • Featured content
    In this downloadable slideset, Sherilyn C. Brinkley, MSN, CRNP; Jordan J. Feld, MD, MPH; Jason Grebely, BSc, PhD; Nancy Reau, MD, FAASLD, AGAF; and Phoebe Sebhatu, PharmD, BCPS, review best practices in addressing practical aspects of managing patients with HCV, including interpretation of current guidelines and payer policies, approaches to patient education and engagement in care, specialty pharmacy utilization and navigation of the insurance appeals process, and management of drug users and patients who become reinfected.
    Date Posted: 11/28/2016
  • Featured content
    In this downloadable slideset, Stephen A. Harrison, MD, COL (Ret.), FAASLD, reviews the latest emerging and investigational therapies and strategies for improving the care of patients with NASH.
    Date Posted: 11/22/2016
  • Featured content
    In this downloadable slideset, Quentin M. Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP, reviews the pathophysiology and pathogenesis of NASH.
    Date Posted: 11/22/2016
  • Featured content
    In this downloadable slideset, Osama E. Rahma, MD, provides an overview of immunotherapy in cancer, including tumor immunology and evolution of immune checkpoint inhibitors in solid tumors, from a satellite symposium at the 2016 American Association for the Study of Liver Diseases Annual Meeting.
    Date Posted: 11/11/2016
  • Featured content
    In this downloadable slideset, Leonard H. Calabrese, DO; Robert P. Perrillo, MD, FAASLD; and Andrew D. Zelenetz, MD, PhD, review HBV reactivation risk, screening, and prophylaxis for patients who will undergo immunosuppressive therapy.
    Date Posted: 10/18/2016
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Slidesets

10 of 243 Shown
10 of 243 Shown
Show 10 More
Loading...